Literature DB >> 7066818

Propranolol in psychiatric illness.

I Ray.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7066818      PMCID: PMC1863244     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN: 0008-4409            Impact factor:   8.262


× No keyword cloud information.
  7 in total

1.  PHYSIOLOGICAL AND CLINICAL EFFECTS OF AMYLOBARBITONE SODIUM THERAPY IN PATIENTS WITH ANXIETY STATES.

Authors:  L WING; M H LADER
Journal:  J Neurol Neurosurg Psychiatry       Date:  1965-02       Impact factor: 10.154

2.  Some effects of propranolol on the central nervous system.

Authors:  G Leszkovszky; L Tardos
Journal:  J Pharm Pharmacol       Date:  1965-08       Impact factor: 3.765

3.  Active and passive avoidance learning in controls and schizophrenic patients on racemic propranolol and neuroleptics.

Authors:  J Gruzelier; S Thornton; D Staniforth; S Zaki; N Yorkston
Journal:  Br J Psychiatry       Date:  1980-08       Impact factor: 9.319

4.  Propranolol in schizophrenia. Clinical, metabolic, and pharmacological findings.

Authors:  T Hanssen; T Heyden; I Sundberg; G Alfredsson; H Nybäck; L Wetterberg
Journal:  Arch Gen Psychiatry       Date:  1980-06

5.  High-dose propranolol in schizophrenia.

Authors:  G P Sheppard
Journal:  Br J Psychiatry       Date:  1979-05       Impact factor: 9.319

6.  Propranolol in chronic schizophrenia: a controlled study in neuroleptic-treated patients.

Authors:  L H Lindström; E Persson
Journal:  Br J Psychiatry       Date:  1980-08       Impact factor: 9.319

7.  Propranolol as an adjunct to the treatment of schizophrenia.

Authors:  N J Yorkston; S A Zaki; D R Pitcher; J H Gruzelier; D Hollander; H G Sergeant
Journal:  Lancet       Date:  1977-09-17       Impact factor: 79.321

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.